Philips Biosensor BX100

History

2020: Beginning of sales

At the end of May, 2020 Philips began sales of the "plaster" measuring the frequency of breath and reductions of heart to help with monitoring of patients with COVID-19. The new product received the name Philips Biosensor BX100.

It is the disposable device which can be carried up to 5 days and which should provide monitoring of several patients in different chambers. BX100 fastens to a breast and collects, stores and transfers data on the frequency of breath and heart rate every minute. The device does not require cleaning or charging. The wearable biosensor allows patients to move on all department or hospital as uses wireless technology for data transmission and alarms.

Philips began sales of the "plaster" measuring the frequency of breath and reductions of heart

The biosensor weighs about 10 g, is steady against blows and vibration and can sustain falling from height of 1 m. It is water-proof and equipped with 1 MB non-volatile a flash memory. This device includes IntelliVue GuardianSoftware software from Philips, the intellectual analytical platform for early warning of deviations and also the advanced monitor of patients of EarlyVue VS30.

In the context of a pandemic of a coronavirus, the solution in the field of remote monitoring of patients are considered as the major tools which allow doctors to control a status of patients without contact with them, thereby preventing spread of a virus.

Using this new biosensor we can control continuously and remotely patients that is especially important in departments with sick COVID-19, - Florian van der Hunnik, the chief specialist on nurse business and the head of department of COVID-19 in OLVG hospital where they passed tests of the new monitor explained. - We cannot enter into chambers of patients without means of individual protection and we welcome this innovation as the BX100 biosensor will help us to perform the work better.[1]

Notes